Show channels:
All channels
Bladder cancer
Brain and spinal
Breast cancer
Cervical
Colon & rectal
Dermatological
General Information
Gynecological
Head and Neck
Kidney/adrenal
Liver
Lung
Lymphoma
Multiple Myeloma
Myelodysplastic syndromes
Myeloproliferative disorders
Pancreas
Pediatric
Prostate
Sarcoma
Stomach
Testicular
Thyroid
Upper aerodigestive
Found 15757 articles
Folate Functionalized and Evodiamine-Loaded Pluronic Nanomicelles for Augmented Cervical Cancer Cell Killing.
ENM showed dose-dependent and time-dependent cytotoxicity against HeLa human cervical cancer cells.
»
05/03/23
A comprehensive analysis of different types of databases reveals that CDH1 mRNA and E-cadherin protein are not downregulated in most carcinoma tissues and carcinoma cell lines
CDH1 gene mRNA and E-cad protein levels positively correlated.
»
05/15/23
Androgen Deprivation and Radiotherapy with or Without Docetaxel for Localized High-risk Prostate Cancer: Long-term Follow-up from the Randomized NRG Oncology RTOG 0521 Trial.
Data suggest that docetaxel should not be used for high-risk localized prostate cancer.
»
11/07/22
Tissue factor as a novel diagnostic target for early detection of ovarian cancer using ultrasound microbubbles.
TF-targeted microbubbles successfully bound to TF-expressing OC cells.
»
07/22/22
Combination therapy with anti-programmed cell death 1 antibody plus angiokinase inhibitor exerts synergistic antitumor effect against malignant mesothelioma via tumor microenvironment modulation.
Nintedanib had potential to suppress protumor activity of TAMs both numerically and functionally.
»
03/16/23
Metformin, placebo, and endocrine therapy discontinuation among participants in a randomized double-blind trial of metformin vs placebo in hormone receptor-positive early-stage breast cancer (CCTG MA32).
Treatment arm allocation did not impact ET adherence.
»
12/14/22
RIPK1 and RIPK3 are positive prognosticators for cervical cancer patients and C2 ceramide can inhibit tumor cell proliferation
in vitro
.
RIPK1 and RIPK3 independent positive predictors for overall survival.
»
11/29/22
Checkpoint blockade and BRAF/MEK therapy in the therapeutic setting improved the overall survival after sentinel node biopsy: A retrospective study comparing patients with primary care between 1998-2009 and 2010-2017.
MSS benefit significant even with low SN tumor burden.
»
01/06/23
Targeting metabolism by B-raf inhibitors and diclofenac restrains the viability of BRAF-mutated thyroid carcinomas with Hif-1α-mediated glycolytic phenotype.
Specific metabolic gene signature identified as hallmark of BRAF-mutated tumours.
»
10/07/22
Watch and wait after neoadjuvant treatment in rectal cancer: comparison of outcomes in patients with and without a complete response at first reassessment in the International Watch & Wait Database (IWWD).
Higher organ preservation rate in group with near-cCR categorized exclusively by MRI.
»
10/28/22
< Prev
Next >